Epstein Secrets

ears at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long and varied career. At the Memorial Sloan-Kettering Cancer Center in New York, he was an attending physician in the Department of Medical Oncology and head of the Laboratory of Tumor Biology. He was also Assistan

l. He subsequently taught at many other universities, including Columbia, NYU, Boston University, the University of California, both at Irvine and Berkeley, before finally becoming a professor at George Mason University, then moving in 1995 to Princeton University, where he has taught poetry workshops

Following his work in BattleBots, he has taken steps into the field of human-robot interactions. "We build these robots and we take them down to Berkeley and study the interactions that people have with the robots," says Wright. "We built this newer one that has a rapid-fire pingpong cannon. It will

ylvania School of Medicine in 1991. Agus completed his residency training at Johns Hopkins Hospital and completed his oncology fellowship training at the Memorial Sloan-Kettering Cancer Center in New York. He spent two years at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long

hall. He subsequently taught at many other universities, including Columbia, NYU, Boston University, the University of California, both at Irvine and Berkeley, before finally becoming a professor at George Mason University, then moving in 1995 to Princeton University, where he has taught poetry workshops an

bits of machined metal left over from his BattleBots days strewn about the garage of his Oakland home. Wright was a former Robot Wars champion in the Berkeley-based robotics workshop, the Stupid Fun Club. One of Wright’s bots, designed with the help of Wright’s daughter Cassidy, “Kitty Puff Puff”, fought ag

ancer How “exceptionalresponders’ ‘arerevolutionizing treatment for the deadly desease BY KAT MCGOWAN UST LIKE EVERY NEW drug the oncologists at Memorial Sloan-Kettering Cancer Center test- ed against bladder cancer in the last 20 years, this one didn’t seem to be doing any good. For- ty-four people in the study were given everolim

“complete response,” Solit says. She’s doingfine. © kat mcgowan is acontributing editor at Discover magazine and an independent journalist based in Berkeley, Calif., and New York City. HOUSE_OVERSIGHT_015499 --- PAGE BREAK --- EDUCATION@NAUTIL. US HOUSE_OVERSIGHT_015500